NCT02400320View on ClinicalTrials.gov

Local Skin Safety Study of a Topical Pain Relief Spray Containing a Combination of Diclofenac, Methyl Salicylate, and Menthol

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 1, 2016

Primary Completion Date

June 1, 2016

Study Completion Date

June 30, 2016

Conditions
Skin Irritation
Interventions
DRUG

Topical Spray

Topical spray containing Diclofenac 1.16%, Linseed Oil 3%, Menthol 5%, Methyl salicylate 10%.

DRUG

Topical Gel

Topical gel containing Diclofenac 1.16%, Menthol 5%, Methyl salicylate 10%

OTHER

Saline

Saline

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT02400320 - Local Skin Safety Study of a Topical Pain Relief Spray Containing a Combination of Diclofenac, Methyl Salicylate, and Menthol | Biotech Hunter | Biotech Hunter